ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Japanese approval sought for Avigan to treat COVID-19

Fujifilm drug could receive the green light by year-end

Japan had aimed to approve Avigan as a coronavirus treatment in May but could not secure enough clinical-trial subjects.   © Reuters

TOKYO -- Fujifilm Holdings will soon apply to produce and sell its Avigan antiviral drug as a treatment for the new coronavirus in Japan, Nikkei learned Sunday.

The health ministry could give the go-ahead this year, making Avigan the third drug overall and the first domestically developed drug to receive such approval. Japan previously approved dexamethasone and remdesivir as coronavirus treatments.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more